SAM Pharmaceutical Limited, one of Nigeria’s longest-standing pharmaceutical manufacturers with a legacy spanning over five decades in human and veterinary medicine, has commemorated its 55th anniversary with the commissioning of a state-of-the-art pharmaceutical manufacturing facility in Ota, Ogun State.
The landmark event, held on Wednesday, April 8, 2026, brought together key stakeholders across the healthcare value chain, including government representatives, regulatory authorities, industry leaders, and development partners.
Dignitaries present at the commissioning who all gave goodwill messages included the Deputy Governor of Ogun State, Engr. Noimot Salako-Oyedele; Honourable Minister of State for Health and Social Welfare, Dr. Iziaq Adekunle Salako; Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Christianah Adeyeye; Honourable Member representing Ado-Odo/Ota Federal Constituency, Hon. Tunji Akinosi; Dr. Marcellina Oluwatomi Coker, Ogun State Commissioner for Health ; Dr. Oluwaserimi Adewumi Ajetunmobi , Oyo State Commissioner for Health, HRH Oba Professor Abdulkabir Adeyemi Obalanlege (Lanlege Ekun II), the Olota of Ota, Dr. Abdu Mukhtar National Coordinator, PVAC (The Presidential Initiative For Unlocking the Healthcare Value Chain); Otunba Adeniyi Adebayo, Former Minister of Industry and Trade; Mr. C. Kannan – The Consul General of India ;Registrar of the Pharmacists Council of Nigeria (PCN), Pharm. Ibrahim Babashehu Ahmed; President of the Pharmaceutical Society of Nigeria (PSN), Pharm. Ayuba Tanko Ibrahim; alongside other distinguished guests including traditional rulers, policymakers, and private sector leaders.
The newly commissioned facility is designed in compliance with World Health Organization current Good Manufacturing Practice (cGMP) plant standards and aligns with international regulatory benchmarks. The plant significantly enhances SAM Pharmaceutical’s production capacity, with the capability to manufacture over 400 million tablets, 50 million capsules, 2 million bottles of liquid formulations, and 1 million sachet-based products monthly. Expansion lines are already in development to further scale output and meet growing market demand.
As part of its 55th anniversary activities and commitment to community health, SAM Pharmaceutical also conducted a large-scale corporate social responsibility (CSR) initiative focused on the control of neglected tropical diseases. The company successfully administered deworming treatment to over 5,000 children across communities in Ogun State, contributing to improved child health outcomes and supporting national efforts in the prevention and management of soil-transmitted helminth infections.
Speaking at the event, the Chairman and Managing Director, Mr. Amit Bhojwani, described the facility as a strategic milestone in the company’s evolution.
“This ultra-modern manufacturing plant represents not just the future direction of SAM Pharmaceutical, but also the strength of the foundation we have built over the past 55 years. Our commitment to quality assurance, pharmacovigilance, and regulatory compliance remains unwavering.
With the launch of what we term ‘SAM Pharm 2.0,’ we are positioning the company for the next phase of growth, driven by innovation, advanced formulations, and technologies tailored to meet the dynamic healthcare needs of Nigeria and the African continent.
This WHO cGMP-compliant facility, developed in alignment with global best practices, underscores our readiness to compete at the highest levels and reinforces the message that ‘Made-in-Nigeria’ pharmaceutical products can meet and exceed international standards.
The presence today of esteemed, high-ranking government officials and industry leaders is deeply encouraging. It not only strengthens my resolve to do more, but also serves as a powerful signal to a new generation of entrepreneurs like me that with the support and confidence of our leaders, we too can take bold steps toward building impactful, enduring enterprises.”
SAM Pharmaceutical, a pioneer in veterinary product manufacturing in Nigeria, continues to play a critical role in strengthening local pharmaceutical production, reducing import dependence, and supporting national health security.
The commissioning event concluded with a celebratory cocktail reception at the Lagos Continental Hotel, bringing together stakeholders for an evening of networking and entertainment. Guests were treated to live performances, including a headline appearance by Afrobeats artist Ladipoe, alongside cultural showcases and interactive performances, marking a fitting close to a day of celebration and corporate achievement.
About SAM Pharmaceutical Limited
SAM Pharmaceutical Limited is a leading indigenous pharmaceutical company in Nigeria, engaged in the manufacturing and distribution of high-quality human and veterinary medicinal products. With over 55 years of industry experience, the company remains committed to advancing healthcare outcomes through innovation, quality manufacturing, and strict adherence to regulatory standards.
